OTCMKTS:RLMD

Relmada Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy RLMD

*Your capital is at risk

$6.33

-0.0900 (-1.40%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

RLMD Prediction Chart

RLMD Predictions History

Latest community submissions for RLMD.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Jan 27, 2020	Bullish	$44.53	V	—	1
JosephProxmire128101	Jan 27, 2020	Bearish	$44.53	X	—	0
coryrose128277	Dec 11, 2019	Bearish	$34.04	X	—	1
PumpTheseNumbers Pro	Dec 3, 2019	$33.82 +390.86% Unrealistic Excluded from avg	$34.46	V	98.14%	1
Fazil Ally @FazilAlly.127903	Dec 3, 2019	Bearish	$34.46	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RLMD with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT RELMADA THERAPEUTICS, INC.

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by